Sumitomo Chemical Company, Limited

Sumitomo Chemical Company, Limited

SOMMF
Sumitomo Chemical Company, LimitedUS flagOther OTC
3.64
USD
- -
- -
6.02BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1,372.73
1,454.14
1,286.04
1,185.83
1,339.68
1,418.06
1,361.34
1,398.77
1,691.35
1,770.84
1,496.28
1,593.17
- -
770.49
Basic EPS, GAAP
22.62
31.93
49.84
46.81
81.81
72.17
18.91
28.16
99.16
4.27
-190.69
23.59
- -
-144
Free Cash Flow per Basic Share
118.91
159.6
159.81
113.61
179.35
127.3
64.84
229.03
105.03
-19.55
-124.86
142.45
- -
39.13
Dividend per Share
6
9.01
11.01
13
17
23
22
12
19
25.98
12.01
6.03
- -
5.99
Book Value per Share
326.92
347
389.31
436.16
506.75
556.66
549.02
577.52
650.82
600.23
408.55
446.65
- -
422.78
Tangible Book Value per Share
452.2
559.29
515.84
466.37
548.43
616.74
444.36
496.43
603.28
500.51
383.83
352.88
- -
359.51
Basic Weighted Avg Shares
1,635
1,634
1,634
1,635
1,635
1,635
1,635
1,635
1,635
1,635
1,635
1,636
- -
1,635
Sales/Revenue/Turnover
2,243,794
2,376,697
2,101,764
1,939,069
2,190,509
2,318,572
2,225,804
2,286,978
2,765,321
2,895,283
2,446,893
2,606,281
2,328,515
1,260,018
Operating Margin (%)
4.49
5.36
7.82
4.34
8.93
6.29
5.76
6.54
6.25
-0.84
-17.63
6.61
8.38
-25.77
Depreciation Expense
115,734
119,177
116,602
110,308
107,103
112,495
131,741
136,017
156,667
167,957
157,522
131,597
121,069
78,869
Net Income, GAAP
36,977
52,192
81,451
76,540
133,768
117,992
30,926
46,043
162,130
6,987
-311,838
38,591
60,947
-235,492
Effective Tax Rate (%)
36.24
39.07
28.67
10.82
26.02
19.06
58.31
50.6
25.76
20,387.88
- -
26.52
0.57
- -
Profit Margin (%)
1.65
2.2
3.88
3.95
6.11
5.09
1.39
2.01
5.86
0.24
-12.74
1.48
2.62
-18.69
Working Capital
293,313
391,061
251,720
184,648
225,868
286,089
148,578
493,779
639,151
484,517
232,395
544,387
506,364
384,853
LT Debt
731,591
693,632
604,270
573,476
552,971
582,965
838,139
1,100,677
1,089,190
1,064,463
977,581
1,033,236
910,033
1,048,496
Total Equity
934,506
1,118,216
1,029,079
1,115,903
1,252,214
1,351,886
1,392,592
1,482,119
1,701,977
1,489,189
1,164,366
1,074,415
1,236,673
1,086,495
Return on Invested Capital (%)
3.35
3.75
5.84
3.83
6.98
5.43
2.16
2.64
4.31
161.97
- -
4.96
8.14
- -
Return on Capital (%)
1.46
2.2
3.26
3.13
5.41
4.52
0.67
1.23
5.48
-281.93
- -
6.35
3.24
- -
Return on Common Equity (%)
7.08
9.48
13.54
11.34
17.35
13.57
3.42
5
16.15
0.68
-37.81
5.52
8.26
-29.55

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
585,905
- -
445,890
LT Borrowings
977,581
- -
1,048,496
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,636
- -
1,637
Market Capitalization
557,241
610,759
554,756

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
1,675,882
- -
1,671,123
Cash, Cash Equivalents & STI
248,787
- -
323,809
Accounts Receivable, Net
620,022
- -
550,772
Inventories
709,637
- -
712,355
Total Current Liabilities
1,443,487
- -
1,286,270
Payables & Accruals
- -
- -
- -
ST Debt
585,905
- -
445,890
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.6%
-2.42%
15.1%
Free Cash Flow
35.69%
30.55%
0.74%
Net Income, GAAP
-442.91%
-892.23%
57.93%
Sales/Revenue/Turnover
1.58%
1.2%
-10.66%
Total Cash Common Dividend
12.55%
18.21%
99.47%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
563,143
623,732
619,994
640,024
2,446,893
2025
- -
- -
- -
- -
2,606,281
2026
- -
- -
- -
- -
2,328,515

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-20.27
-26.41
-20.44
- -
-190.69
2025
- -
- -
- -
- -
23.59
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6.01
0.02
5.99
- -
12.01
2025
- -
- -
- -
- -
6.03
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Nobuaki Mito
Full Time Employees
27,491
Sector
Basic Materials
Industry
Chemicals
Address
Tokyo Nihombashi Tower Tokyo TY Japan 103-6020
IPO Date
Sep 11, 2009
Business
Sumitomo Chemical Company, Limited, founded on September 22, 1913 and headquartered in Tokyo and Osaka, Japan, manufactures and sells a broad portfolio of chemical products across four main sectors: Agro & Life Solutions, including crop protection chemicals, fertilizers, agricultural materials, household insecticides, feed additives and biorational products; ICT & Mobility Solutions, encompassing optical products, semiconductor processing materials, compound semiconductors, touch screen sensors, high-purity aluminum, engineering plastics, battery materials and additives; Advanced Medical Solutions, featuring contract development and manufacturing for small-molecule drugs, oligonucleotides, regenerative medicine and cell therapy products; and Essential & Green Materials, comprising synthetic resins, methyl methacrylate products, raw materials for synthetic fibers, industrial chemicals, synthetic rubber, aluminum and alumina. The company operates globally, with key facilities and subsidiaries in Asia, Europe, the Americas and the Middle East, serving industries such as agriculture, automotive, electronics, construction, pharmaceuticals and energy. It also provides ancillary services including electric power and steam supply, chemical plant design and construction, transportation, warehousing and environmental analysis. In recent developments, Sumitomo Chemical announced a 400 billion yen investment plan in March 2025 under its medium-term management strategy 'Leap Beyond - Return to Growth Track,' targeting growth in agrochemicals, semiconductors and display technologies, with over 220 billion yen allocated to research and development aiming for core operating income of 200 billion yen by fiscal 2028. The company fully acquired French crop protection firm Philagro Holding S.A. and Spanish firm Kenogard S.A. in early 2025 to expand its European crop protection business, integrating operations with its subsidiary Sumitomo Chemical Agro Europe S.A.S. and targeting more than doubled sales by 2030. Additional strategic moves include a September 2025 memorandum of understanding with Mitsui Chemicals and Idemitsu Kosan to integrate its polypropylene and LLDPE businesses into Prime Polymer; an agreement in November 2025 to acquire a Taiwanese semiconductor process chemicals company for bases in Taiwan and the U.S.; plans to make Tanaka Chemical Corporation a wholly-owned subsidiary via share exchange in October 2025; establishment of RACTHERA Co., Ltd. joint venture with Sumitomo Pharma in February 2025 for regenerative medicine research; and restructuring of its U.S. agro & life solutions group companies plus lithium-ion battery separator business in late 2025.